Percutaneous coronary intervention for acute coronary syndromes: No difference in 30-day efficacy or safety of high- and low-dose aspirin; double-dose clopidogrel reduces 30-day risk of cardiovascular death, myocardial infarction or stroke compared with standard dose but increases risk of major bleeding

Anuradha Lala, Jeffrey S. Berger

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)80-81
Number of pages2
JournalEvidence-Based Medicine
Issue number3
StatePublished - Jun 2011
Externally publishedYes

Cite this